Artículos por temáticas

Basic approach on the protective effects of hesperidin and naringin in Alzheimer's disease

Kuşi M, Becer E, Vatansever HS.

Nutr Neurosci. 2025 May;28(5):550-562. doi: 10.1080/1028415X.2024.2397136. Epub 2024 Sep 3.

Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia

Vollhardt A, Frölich L, Stockbauer AC, Danek A, Schmitz C, Wahl AS.

Neurobiol Dis. 2025 May;208:106845. doi: 10.1016/j.nbd.2025.106845. Epub 2025 Feb 24.

Nutritional interventions for preventing cognitive decline in patients with mild cognitive impairment and Alzheimer's disease: A comprehensive network meta-analysis and Mendelian Randomization study

He Q, Bennett AN, Zhang C, Zhang JY, Tong S, Chan KHK.

Clin Nutr ESPEN. 2025 Jun;67:555-566. doi: 10.1016/j.clnesp.2025.03.040. Epub 2025 Mar 25.

Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease

Cline EN, Antwi-Berko D, Sundell K, Johnson E, Hyland M, Zhang H, Vanderstichele H, Kaplow J, Dean RA, Stoops E, Vanmechelen E, Koel-Simmelink MJA, Teunissen CE, Sethuraman G, Feaster T, Siemers E, Je

J Prev Alzheimers Dis. 2025 Apr;12(4):100082. doi: 10.1016/j.tjpad.2025.100082. Epub 2025 Feb 17.

Iridoid glycosides in kidney-tonifying Chinese medicinal herbs: Mechanisms and implications for Alzheimer's disease therapy

Qu Y, Ding M, Zhang M, Zheng L, Hu B, An H.

J Ethnopharmacol. 2025 May 28;348:119870. doi: 10.1016/j.jep.2025.119870. Epub 2025 Apr 25.

Nano-Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type-2 Diabetes Mellitus

Siddiqui F, Mishra P, Khanam S, Ranjan S, Alam P, Albalawi T, Khan S, Mir SS.

Eur J Neurosci. 2025 May;61(10):e70142. doi: 10.1111/ejn.70142.

Neuroprotective Properties of Clove (Syzygium aromaticum): State of the Art and Future Pharmaceutical Applications for Alzheimer's Disease

Sargsyan T, Simonyan HM, Stepanyan L, Tsaturyan A, Vicidomini C, Pastore R, Guerra G, Roviello GN.

Biomolecules. 2025 Mar 20;15(3):452. doi: 10.3390/biom15030452.

RNA-Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins

Rabbani SA, El-Tanani M, Sharma S, El-Tanani Y, Kumar R, Saini M, Yadav M, Khan MA, Parvez S.

Eur J Neurosci. 2025 Apr;61(8):e70110. doi: 10.1111/ejn.70110.

Reevaluating Alzheimer's disease treatment: Can phytochemicals bridge the therapeutic Gap?

Roy KK, Mehta DK, Das R.

Neuroscience. 2025 May 24;575:1-18. doi: 10.1016/j.neuroscience.2025.04.014. Epub 2025 Apr 10.

Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease

Ren Y, Pieper AA, Cheng F.

Neurotherapeutics. 2025 Apr;22(3):e00553. doi: 10.1016/j.neurot.2025.e00553. Epub 2025 Feb 17.

The role of semaphorin 3A in the pathogenesis and progression of Alzheimer's disease and other aging-related diseases: A comprehensive review

Yuan J, Huang R, Nao J, Dong X.

Pharmacol Res. 2025 May;215:107732. doi: 10.1016/j.phrs.2025.107732. Epub 2025 Apr 11.

Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease

Soni P, Sharma SM, Pieper AA, Paul BD, Thomas B.

Neurotherapeutics. 2025 Apr;22(3):e00586. doi: 10.1016/j.neurot.2025.e00586. Epub 2025 Apr 7.

Stress and Hypertension Among African American Female Family Caregivers of Persons Living With Alzheimer Disease and Related Dementias: Protocol for a Pilot Internet-Based Randomized Controlled Trial

Wright KD, Richards Adams IK, Helsabeck NP, Rose KM, Moss KO, Nemati D, Palmer N, Kim B, Pokhrel Bhattarai S, Nguyen C, Addison D, Klatt MD.

JMIR Res Protoc. 2025 Mar 27;14:e66975. doi: 10.2196/66975.

Transcranial electrical stimulation as a therapeutic strategy for Alzheimer's disease: Current uses and challenges

Wang H, Qin N, Maimaitiaili D, Wu J, Wang S, Zhou Y, Lu J, Li Y.

J Alzheimers Dis. 2025 Mar;104(2):297-305. doi: 10.1177/13872877251315777. Epub 2025 Feb 24.

Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer's activity in aluminum chloride-induced Alzheimer's-like disease in rats: Impact on α7 nicotinic acetylcholine receptors and amyloid β

Abdel-Aal RA, Meligy FY, Maghraby N, Sayed N, Mohamed Ashry IE.

Brain Res. 2025 May 15;1855:149573. doi: 10.1016/j.brainres.2025.149573. Epub 2025 Mar 15.